Log In
BCIQ
Print this Print this
 

STS, sodium thiosulfate

  Manage Alerts
Collapse Summary General Information
Company Fennec Pharmaceuticals Inc.
DescriptionSodium thiosulfate
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationHearing loss
Indication DetailsPrevent hearing loss associated with platinum-based chemotherapies in children; Reduce ototoxicity
Regulatory Designation U.S. - Orphan Drug (Prevent hearing loss associated with platinum-based chemotherapies in children)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today